;Mesp1-Cre heart at E10.5. As seen in E11.5 hearts, whilst overall alignment defects can be seen, there is no hypocellularity defect in the cushions or gross tissue loss. ; v, ventricle; a, atrium; avc, atrioventricular canal. 
Oft indicates outflow tract
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Figure S6: CHD7 protein levels in the developing heart (A) Western blot time course showing CHD7 levels in whole heart protein extracts between E10.5 to E15.5. The high level of CHD7 protein at E10.5 then then decreases until it is barely detectable by E13.5. The +ve lane is protein extracted from murine ESCs and the -ve lane is protein from HEK293T cells. The Western blot for the nuclear protein Lamin B1 is also shown as a loading control.
(B) Immunofluorescence on cryosections through wild-type CD1 hearts between developmental stages E10.5 to E13.3. Ubiquitous CHD7 expression was seen at E10.5 in the pharyngeal region (Bi) and throughout the heart (Bii). Higher magnification imaging showed overlap with DAPI staining, confirming its nuclear localisation. Similar widespread CHD7 expression was seen at E11.5 in the endocardial cushions and endothelial lining of the outflow tract (Biii) and again in the myocardium and endocardium of the ventricles (Biv). However, at E13.5, CHD7 protein could no longer be detected anywhere in the OFT region (Bv) or the heart (Bvi) by immunohistochemistry. 
Supplemental Tables
Histology
Dissected embryos were fixed overnight in 4% PFA/PBS and then dehydrated through an ethanol series, cleared by washing in histoclear (National Diagnostics), and embedded in paraffin after overnight washes. A microtome was used to section embryos to 12-15µm thickness in a coronal or transverse plane, and sections were transferred onto 3-triethoxysilylpropylamine (TESPA)-coated glass slides. For morphological examination, sections were rehydrated and stained using freshly-filtered Mayer's Hemotoxylin solution (Sigma-Aldrich) followed by aqueous Eosin solution (Sigma-Aldrich). Slides were mounted with glass coverslips using DPX solution (Merck).
For quantitation of the thickness and compaction of the ventricular walls in E15.5 hearts, three different non-consecutive transverse sections through 5 control and 5 mutant hearts were examined, with ImageJ used to take measurements of the width (in mm) across the compact layer and trabeculae at three different points around both the left and right ventricles in each section. The mean widths were then calculated and plotted with the standard error, and the mean percentage of the total ventricular wall thickness that each layer comprised was calculated. Statistical analysis was performed using the unpaired student t test.
Intracardiac Ink Injection
After overnight fixation of embryos in 4% PFA/PBS at 4°C, E10.5 outflow tracts were injected with India ink (Pélican) using a pulled glass capillary to fill the 3 rd , 4 th and 6 th pharyngeal arch arteries (as previously described [1]). Fixed E15.5 embryos were opened to view the chest cavity and India ink injected into the cardiac ventricles when insufficient blood remained in the great vessels to view their structure.
Immunofluorescence on Wax Sections
Tissue sections were prepared in the same way as for Hemotoxylin and Eosin staining (see above). Slides were de-waxed by pre-warming at 60°C followed by two 10 minute washes in histoclear, and rehydrated by 5 minute washes through an EtOH series down to 30% EtOH. Antigen retrieval was carried out by incubation in pre-warmed Target Retrieval Solution (Dako) for 30 minutes at 94-96°C, 20 minutes at room temperature, and then 5 minutes under running water. Sections were then incubated for 1 hour at room temperature in blocking solution (1% BSA, 2% FBS (Life Technologies), PBS) followed by incubation overnight at 4°C in primary antibodies. Slides were then rinsed in PBS and incubated in secondary antibodies (Invitrogen) diluted 1:500 in blocking solution for 1 hour at room temperature, and then, where required, tertiary antibody diluted 1:500 for another 30 minutes. Finally, slides were rinsed further in PBS, stained with DAPI and mounted with glass coverslips using VECTASHIELD® mounting medium.
Primary antibodies used were mouse monoclonal to Islet1 (40.2D6, Developmental Studies Hybridoma Bank) diluted 1:25, golden Syrian hamster monoclonal to Podoplanin (NB600-1015, Novus) diluted 1:100, and rabbit monoclonal to WT1 (ab89901, Abcam) diluted 1:100 in blocking solution. Secondary antibodies were Biotinylated goat anti-mouse IgG (Vector Laboratories), AlexaFluor® 488 goat anti-Syrian hamster IgG (Life Technologies), and AlexaFluor® 594 goat anti-rabbit IgG (Life Technologies). The tertiary antibody was AlexaFluor® 594-conjugated Streptavadin.
Immunofluorescence on Cryosections
Embryos were fixed in 4% PFA/PBS at 4°C for 30-60 minutes, washed in PBS and then incubated overnight in 30% sucrose/PBS at 4°C. This was followed by incubation in a 50/50 mixture of 30% sucrose/OCT embedding matrix (Fisher) until the embryos sank, and then incubation in 100% OCT. Samples were mounted into moulds on dry ice and stored at -80°C before crysectioning at 10µM thickness onto Superfrost Plus slides (VWR).
For immunofluorescence staining, sections were brought to room temperature, rinsed twice in PBS and permeabilised with 0.5% Triton X-100 (Sigma-Aldrich)/PBS for 10 minutes before further rinsing in PBS. Sections were incubated for 1 hour in blocking solution (1% BSA, 10% goat serum, 0.1% Triton X-100) in a humidified chamber, then incubated overnight at 4°C in rabbit polyclonal to CHD7 (NBP1-77393, Novus Biologicals) diluted 1:200 in blocking solution. Following washes in 0.1% Triton X-100/PBS and then PBS, slides were incubated in AlexaFluor® 594 goat anti-rabbit-IgG (Life Technologies) diluted 1:1000 in blocking solution before finally washing again and counter-staining with DAPI.
Visualising Parasympathetic Innervation on Wholemount Hearts
E15.0 hearts were dissected into PBS before fixation for 20-30 minutes in 4% PFA/PBS at room temperature. Hearts were then permeabilised by incubation in 0.5% Triton-X/PBS for 5 minutes, washed in PBS and stored overnight at 4°C in blocking solution (1% BSA, 10% sheep serum, 0.1% Triton-X). Hearts of the required genotype were then incubated overnight at 4°C with rotation in rabbit monoclonal antibody to Neurofilament-66 (04-1032, Millipore) diluted 1:50 in blocking solution, washed in PBS at room temperature, incubated overnight at 4°C in AlexaFluor® 594 goat anti-rabbit-IgG (Life Technologies) diluted 1:1000 in blocking solution, and finally washed again in PBS. The dorsal views of the hearts were photographed using a Zeiss SteREO Lumar.V12 microscope equipped with an AxioCam HRc camera and UV lamp and images processed using ImageJ.
Visualising Coronary Veins on Wholemount Hearts
E15.5 hearts were dissected into PBS, fixed in 4% PFA/PBS for 40 minutes at room temperature, washed in PBS and then dehydrated through a methanol (MeOH) series and stored at -20°C in 100% MeOH until genotyped. After rehydration to PBS, hearts were permeabilised by washing twice in 0.1% Tween-20/PBS (PBT) before incubation for two hours at room temperature in blocking solution (10% goat serum in PBT) and then overnight incubation in rat monoclonal to Endomucin (sc-65495, Santa Cruz) diluted 1:50 in blocking solution. Samples were washed in PBT at room temperature and then incubated overnight at 4°C in secondary Alexafluor-594-conjugated anti-rat-IgG antibody (Invitrogen) diluted 1:1000 in blocking solution. Hearts were again photographed using a Zeiss SteREO Lumar.V12 microscope equipped with an AxioCam HRc camera and UV lamp and images processed using ImageJ.
qRT-PCR
Total RNA was prepared using the same method as for the microarrays. The High-Capacity Reverse Transcription Kit with RNase Inhibitor (Applied Biosystems) was used to make cDNA, of which 600ng per lane was loaded on custom-designed TaqMan® Array Micro Fluidic Cards, according to manufacturer's instructions. Cards were run on an Applied Biosystems 7900HT Fast Real-Time PCR System using a
